Who is the culprit? A toxic epidermal necrolysis case in a patient treated with rituximab plus polatuzumab.

Zengarini, C; Misciali, C; Robuffo, S; Piraccini, B M; Pileri, A

Zengarini, C; Misciali, C; Robuffo, S; Piraccini, B M; Pileri, A.

Afiliación

Zengarini C; Dermatology Unit, IRCCS of Azienda Ospedaliero-Universitaria di Bologna, via Massarenti 9, Bologna, Italy.
Misciali C; Dermatology, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Robuffo S; Dermatology Unit, IRCCS of Azienda Ospedaliero-Universitaria di Bologna, via Massarenti 9, Bologna, Italy.
Piraccini BM; Dermatology, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Pileri A; Dermatology Unit, IRCCS of Azienda Ospedaliero-Universitaria di Bologna, via Massarenti 9, Bologna, Italy.

J Eur Acad Dermatol Venereol ; 36(10): e782-e783, 2022 10.

Article en En | MEDLINE | ID: mdl-35607916

Asunto(s)

Síndrome de Stevens-Johnson; Humanos; Rituximab/efectos adversos; Síndrome de Stevens-Johnson/tratamiento farmacológico; Síndrome de Stevens-Johnson/etiología

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome de Stevens-Johnson Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Asunto de la revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google